js006
mAbexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 21, 2021 (NCT05061628)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05757492 | Phase 1/Phase 2 (Phase 2) | Apr 26, 2023 | Coherus BioSciences, Medpace, Inc., Shanghai Junshi Bioscience Co.,Ltd. |
| NCT05253105 | Phase 1 | Mar 15, 2022 | CTI Clinical Trial and Consulting Services, Shanghai Junshi Bioscience Co.,Ltd. |
| NCT05061628 | Phase 1 | Apr 21, 2021 | Shanghai Junshi Bioscience Co.,Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Junshi Bioscience Co.,Ltd. | For profit | 3 | 2 | 2 | 2021 |
| Coherus BioSciences | For profit | 1 | 1 | 1 | 2023 |
| CTI Clinical Trial and Consulting Services | For profit | 1 | 0 | 1 | 2022 |
| Medpace, Inc. | For profit | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1